Michael A. Burgess

Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria

Haesun Choi, C Charnsangavej, Silvana C. Faria et al. · Journal of Clinical Oncology · 2007 · 1.5K citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib

Robert H.I. Andtbacka, Chaan S. Ng, Courtney L. Scaife et al. · Annals of Surgical Oncology · 2006 · 269 citations

Medicine, Oncology, Surgery +13

Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-Guérin

Jordan U. Gutterman, Giora M. Mavligit, Jeffrey A. Gottlieb et al. · New England Journal of Medicine · 1974 · 193 citations

Medicine, Immunology, Oncology +16

Phase I Trial of Preoperative Concurrent Doxorubicin and Radiation Therapy, Surgical Resection, and Intraoperative Electron-Beam Radiation Therapy for Patients With Localized Retroperitoneal Sarcoma

Peter W. T. Pisters, Matthew T. Ballo, Mark J. Fenstermacher et al. · Journal of Clinical Oncology · 2003 · 152 citations

Medicine, Oncology, Surgery +15

Is there a role for surgery in patients with “unresectable” cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?

Courtney L. Scaife, Kelly K. Hunt, Shreyaskumar Patel et al. · The American Journal of Surgery · 2003 · 138 citations

Medicine, Oncology, Surgery +9